A practical reference on stability: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-11-12. Anything still debated is marked as such rather than presented as settled.
Storage conditions for reconstituted peptides are product-specific. Cool temperatures slow many degradation pathways, but freezing can concentrate solutes and promote aggregation. Light exposure can oxidize susceptible residues such as methionine, cysteine, or tryptophan. Oxygen in headspace can contribute to oxidation, while acidic or basic pH can drive hydrolysis and deamidation. The best storage condition for a given sequence is often determined empirically because general rules do not capture all sequence-specific effects.
Quality control of reconstituted peptides combines visual inspection with instrumental analysis. A clear solution does not prove correct identity or purity, and a cloudy solution does not always indicate failure. Reverse-phase high-performance liquid chromatography can separate the peptide from related impurities, while mass spectrometry confirms molecular mass and detects modifications. pH measurement and osmolality checks provide additional information about the solution environment, and documentation of lot number, solvent, and storage history supports traceability.
Documentation supports reproducibility and traceability. Records often include lot number, solvent composition, final concentration, preparation date, and storage location. Such details help distinguish procedural variation from actual sample instability. Questions remain about how best to predict long-term stability from short-term accelerated studies, because peptide degradation pathways differ widely. For many peptides, the relationship between in vitro solution stability and biological behavior is incompletely understood and is an active area of research.
After reconstitution, a peptide solution is typically stored under conditions that limit degradation. Cool temperatures slow hydrolysis and oxidation, while freezing can preserve samples for longer periods. Repeated freeze-thaw cycles may promote aggregation or precipitation, so aliquoting before freezing is a common laboratory practice. The optimal storage temperature depends on the peptide sequence, buffer composition, and expected duration. Solutions containing oxidizable residues may benefit from inert gas overlays or antioxidants, though compatibility with the specific peptide must be considered.
Aseptic technique matters because aqueous peptide solutions can support microbial growth. Sterile solvents, clean workspaces, and sterile filtration can reduce contamination. The choice of filter material and pore size must avoid peptide loss through adsorption, especially for hydrophobic or low-concentration samples. Visual inspection for particles, turbidity, or color change provides a simple initial check, but it cannot confirm identity or purity. Analytical methods such as reversed-phase high-performance liquid chromatography and mass spectrometry are used to verify composition and detect degradation products.
| Property | Value | Notes |
|---|---|---|
| Appearance of reconstituted solution | Clear to slightly opalescent | Turbidity or visible particles may indicate aggregation or incomplete dissolution. |
| pH range | Peptide-dependent | Buffer choice should be based on stability data when available. |
| Typical storage temperature for lyophilized powder | −20 °C or below | Desiccant and a sealed container reduce moisture uptake. |
| Typical storage temperature for reconstituted solution | 2–8 °C | Freezing may be used for longer intervals, but freeze-thaw cycles can promote aggregation. |
| Identity confirmation method | Mass spectrometry | Confirms molecular mass and detects chemical modifications. |
Once reconstituted, a peptide solution is generally less stable than the dry powder. Hydrolysis, oxidation, aggregation, and microbial growth can change the preparation over time, so storage temperature and duration are practical concerns. Dividing a solution into single-use aliquots before freezing can reduce repeated freeze-thaw cycles, which may otherwise cause precipitation or loss of activity. The optimal storage conditions vary by peptide, and no single rule applies to all sequences. Records of solvent, concentration, date, and storage history help maintain traceability. Studies often report stability under defined conditions rather than universal shelf lives.
Reconstitution is the process of dissolving a lyophilized peptide powder in a suitable liquid to produce a solution for laboratory or clinical use. The dry powder is typically a porous cake or fluffy solid formed by freeze-drying an aqueous or mixed-solvent preparation. Adding solvent restores the peptide to a dissolved state, but the result is not necessarily identical to the original pre-lyophilization solution. Factors such as pH, ionic strength, temperature, and the peptide's sequence influence how completely and quickly dissolution occurs. The term is distinct from dilution, which lowers concentration without changing the physical state of an already dissolved material.
Quality checks after reconstitution include visual inspection, pH measurement, and analytical methods such as reversed-phase high-performance liquid chromatography. These tests can detect insoluble material, degradation products, and changes in concentration. Mass spectrometry is often used to confirm molecular identity when the peptide sequence is known. Because a clear solution can still contain aggregates or modified peptide, visual clarity alone is not sufficient. Analytical results are compared with a reference standard or the pre-reconstitution certificate of analysis.
Container selection matters because peptides can adsorb to glass, plastic, and filter membranes. Low-binding polypropylene tubes reduce losses for hydrophobic sequences, and filtration through a 0.22 µm membrane can remove particulates and microorganisms. Some peptides may bind to certain filter materials, so compatibility should be checked. Aliquots should be prepared before freezing to avoid repeated temperature cycling. Labels should record the peptide identity, lot number, solvent, concentration, reconstitution date, and storage condition.
After reconstitution, the peptide solution is less stable than the dried powder because water enables hydrolysis, oxidation, and microbial growth. Storage temperature, pH, buffer composition, and container material all affect how long the solution remains usable. Many peptides are kept at 2–8 °C for short-term work, while frozen aliquots at −20 °C or below are used for longer intervals. Repeated freeze-thaw cycles can cause aggregation or precipitation. The choice of storage condition should be based on stability data for the specific peptide.
=== Other defunct Soviet states === Ukrainian People's Republic of Soviets (1917–1918) → Ukrainian Soviet Republic (1918) Bessarabian Soviet Socialist Republic (1919) Socialist Soviet Republic of Lithuania and Belorussia (1919–1920) Galician Soviet Socialist Republic (1920)
== Signs and symptoms == Most individuals with G6PD deficiency are asymptomatic. When it induces hemolysis, the effect is usually short-lived. Most people who develop symptoms are male, due to the X-linked pattern of inheritance, but female carriers can be affected due to unfavorable lyonization or skewed X-inactivation, where random inactivation of an X chromosome in certain cells creates a population of G6PD-deficient red blood cells coexisting with unaffected red blood cells. A female with one affected X chromosome will show the deficiency in approximately half of her red blood cells. However, in some cases, including double X-deficiency, the ratio can be much more than half, making the individual almost as sensitive as males. Red blood cell breakdown (also known as hemolysis) in G6PD deficiency can manifest in many ways, including the following:
Most of the Afghan population was already going hungry at the time of the attacks. In the aftermath of the attacks, tens of thousands of people attempted to flee Afghanistan due to the possibility of military retaliation by the U.S. and Pakistan, already home to many Afghan refugees from previous conflicts, closed its border with Afghanistan on September 17, 2001. Thousands of Afghans also fled to the frontier with Tajikistan but were denied entry. The Taliban leaders in Afghanistan pleaded against military action, saying "We appeal to the United States not to put Afghanistan into more misery because our people have suffered so much", referring to two decades of conflict and the humanitarian crisis attached to it. All United Nations expatriates had left Afghanistan after the attacks and no national or international aid workers were at their post. Workers were instead preparing in bordering countries like Pakistan, China and Uzbekistan to prevent a potential "humanitarian catastrophe", amid a critically low food stock for the Afghan population. The World Food Programme stopped importing wheat to Afghanistan on September 12 due to security risks.
== Applications == As of 2021 no DNA vaccines have been approved for human use in the United States. Few experimental trials have evoked a response strong enough to protect against disease and the technique's usefulness remains to be proven in humans. A veterinary DNA vaccine to protect horses from West Nile virus has been approved. Another West Nile virus vaccine has been tested successfully on American robins. DNA immunization is also being investigated as a means of developing antivenom sera. DNA immunization can be used as a technology platform for monoclonal antibody induction.
The placula hypothesis, proposed by Otto Bütschli, holds that the last common ancestor of animals was an amorphous blob with no symmetry or axis. The center of this blob rose slightly above the silt, forming a hollow that aided feeding on the sea floor underneath. As the cavity grew deeper and deeper, the organisms resembled a thimble, with an inside and an outside. This body shape is found in sponges and cnidaria. This explanation leads to the formation of the bilaterian body plan; the urbilaterian would develop its symmetry when one end of the placula became adapted for forward movement, resulting in left-right symmetry. The planula hypothesis, proposed by Bütschli, suggests that metazoa are derived from planula; that is, the larva of certain cnidaria, or the adult form of the placozoans. Under this hypothesis, the larva became sexually mature through paedomorphosis, and could reproduce without passing through a sessile phase. The gastraea hypothesis was proposed by Ernst Haeckel in 1874, shortly after his work on the calcareous sponges. He proposed that this group of sponges is monophyletic with all eumetazoans, including the bilaterians. This suggests that the gastrulation and the gastrula stage are universal for eumetazoans. It has been perceived as problematic that gastrulation by invagination is by no means universal among eumetazoans. Only recently has an invagination been confirmed in a Calcarea sponge, albeit too early to form a remaining inner space (archenteron).
Sources: en.wikipedia.org
Although benzodiazepines are much safer in overdose than their predecessors, the barbiturates, they can still cause problems in overdose. Taken alone, they rarely cause severe complications in overdose; statistics in England showed that benzodiazepines were responsible for 3.8% of all deaths by poisoning from a single drug. However, combining these drugs with alcohol, opiates or tricyclic antidepressants markedly raises the toxicity. The elderly are more sensitive to the side effects of benzodiazepines, and poisoning may even occur from their long-term use. The various benzodiazepines differ in their toxicity; temazepam appears most toxic in overdose and when used with other drugs. The symptoms of a benzodiazepine overdose may include; drowsiness, slurred speech, nystagmus, hypotension, ataxia, coma, respiratory depression, and cardiorespiratory arrest. A reversal agent for benzodiazepines exists, flumazenil (Anexate), itself belonging to the chemical class of benzodiazepines. Its use as an antidote is not routinely recommended because of the high risk of resedation and seizures. In a double-blind, placebo-controlled trial of 326 people, 4 people had serious adverse events and 61% became resedated following the use of flumazenil. Numerous contraindications to its use exist. It is contraindicated in people with a history of long-term use of benzodiazepines, those having ingested a substance that lowers the seizure threshold or may cause an arrhythmia, and in those with abnormal vital signs.
In 1998, Andrew Wakefield et al. published a now retracted and fraudulent The Lancet paper linking the MMR vaccine to autism, leading to a decline in vaccination rates. Wakefield was later found to have been "dishonest" by the General Medical Council and barred from practicing medicine in the UK. Numerous subsequent studies and reviews by organizations such as the US Centers for Disease Control and Prevention, Institute of Medicine, NHS and the Cochrane Library have found no evidence of a link between the MMR vaccine and autism. The controversy surrounding Wakefield's publication led to decreased MMR vaccination rates and a subsequent increase in measles cases in the UK. In Japan, where the MMR vaccine is not used as a combined vaccine, autism rates have remained unaffected, further disproving Wakefield's hypothesis. According to a 2019 Los Angeles Times article, concerns were raised about unvaccinated students contributing to the large number of measles outbreaks. While Robert F. Kennedy Jr—United States Secretary of Health and Human Services— publicly supported Wakefield's disproven theory that vaccines cause autism, and was the founder of the anti-vaccine Children's Health Defense, on 28 February, during the 2025 Southwest US measles outbreak, he announced that he would be sending 2,000 doses of the MMR vaccine to Texas along with other resources. A New York Times article reporting on the death of a child in Texas from measles—the first in ten years in the United States, said that vaccine hesitancy had been rising for many years.
Guayaquileños are a thousand times get better" It is also denounced that he used to constantly insult Peruvians in private letters, accusing them of barbaric people for their lack of affection for republican ideas, in addition to admitting that he used to give false compliments to Peruvian politicians, to manipulate them so that they do not interfere with his Bolivian Federation project (in the largest project of the Great Homeland), as well as showing indifference to Corruption in Peru, or even encouraging it among the caudillos to weaken Peru (even seeking its total disarmament under the pretext financial insufficiency): "(...) The Empire [Federation of the Andes] will come true, or there will be a deluge of blood in America: therefore I entrust you with energy and perseverance. What do you have to fear from the imbeciles of Peru? Don't you already have the consent of Gamarra and La-Fuente? Aren't our friends the owners of the council of that cabinet, don't they have a majority in lodge 5, aren't they protected by our squad, and guaranteed by my power? Leave me alone with the plainsman Paez, and with these doctors from Bogotá; working well over there, I answer for the event. Meanwhile, that government destroys the liberals under the guise of anarchists. (...) When you see those pusillanimous Gamarra and La-Fuente look pale before the anarchists, ask them to take their cockade for a few days: when they fear too much, authorize them to take a million dollars divisibly from the Peruvian funds.
=== Average chemical characteristics === On average, healthy humans eliminate 128 g of fresh feces per person per day with a pH value of around 6.6 as indicated by a Fecal pH test. Fresh feces contains around 75% water and the remaining solid fraction is 84–93% organic solids along with some insoluble phosphate salts. These organic solids consist of: 25–54% bacterial biomass, 2–25% protein or nitrogenous matter, 25% carbohydrate or undigested plant matter, and 2–15% fat. Protein and fat come from the colon due to secretion, epithelial shedding, and gut bacterial action. These proportions vary considerably depending on many factors but mainly diet and body weight. The remaining solids are composed of insoluble calcium and iron phosphate salts, intestinal secretions, small amounts of dried epithelial cells, and mucus.
Low-certainty evidence indicates that it mitigates worsening of peripheral neuropathy and disability from disease progression. Inotersen blocks gene expression of both wild-type and mutant TTR, reducing amyloid precursor. Moderate-certainty evidence suggests that it mitigates worsening of peripheral neuropathy. Long-term efficacy and safety of inotersen use in people with mutant TTR-related amyloidosis is still be evaluated in a phase-III clinical trial as of 2021. Both diflunisal and inotersen may also mitigate declines in quality-of-life, though the evidence for this effect is unclear. For people with cardiac ATTR the effect of inotersen use is inconclusive and requires further investigation. In 2018, inotersen was approved by the European Medicines Agency to treat polyneuropathy in adults with hereditary transthyretin amyloidosis. It has since been approved for use in Canada, the European Union and in the USA. Patisiran functions similarly to inotersen. Moderate-certainty evidence suggests that patisiran mitigates worsening of peripheral neuropathy and disability from disease progression. Additionally, low-certainty evidence suggests that patisiran mitigates decreases in quality-of-life and slightly reduces the rate of adverse events versus placebo. There is no evidence of an effect on mortality rate. A review of early data from use of patisiran in people with variant cardiac ATTR suggests that it may reduce mortality and hospitalization, however this is still being investigated and requires further investigation.
Sources: en.wikipedia.org
=== Pharmacodynamics === SR-17018 acts as a biased partial agonist of the μ-opioid receptor (MOR), with strong selectivity for activation of G protein signaling over β-arrestin2 recruitment. Its affinities (Ki) for the human opioid receptors have been reported to be 11 nM for the MOR, 68 nM for the κ-opioid receptor (KOR), and >10,000 nM for the δ-opioid receptor (DOR). In terms of MOR activation, the drug had activational potencies and efficacies (EC50Tooltip half-maximal effective concentration and EmaxTooltip maximal efficacy) of 97–193 nM (72–75%) for GTPγS binding, 76 nM (105%) for cAMPTooltip cyclic adenosine monophosphate accumulation, and >10,000 nM (10%) for β-arrestin2 recruitment. Both GTPγS binding and cAMP accumulation are measures of G protein signaling. The drug showed a calculated bias factor for GTPγS binding over β-arrestin2 recruitment of 80 to 100 relative to DAMGO. SR-17018 also showed strong bias for G protein activation over β-arrestin2 recruitment using mouse proteins, albeit with reduced efficacy for GTPγS binding (Emax = 37%). β-Arrestin2 activation may contribute to opioid tolerance, though it is not the only mechanism of tolerance to these drugs. SR-17018 shows a strikingly different MOR phosphorylation profile from other MOR biased, partial, and full agonists. Additional studies have characterized the interactions of SR-17018 with the MOR, including activational potencies and efficacies at downstream signaling pathways, as well.
=== Legal status === On 28 January 2021, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Byfavo, intended for procedural sedation. The applicant for this medicinal product is PAION Netherlands B.V. Remimazolam (Byfavo) was approved for medical use in the European Union in March 2021.
The WHO AWaRe (Access, Watch, Reserve) guidance and antibiotic book has been introduced to guide antibiotic choice for the 30 most common infections in adults and children to reduce inappropriate prescribing in primary care and hospitals. Narrow-spectrum antibiotics are preferred due to their lower resistance potential, and broad-spectrum antibiotics are only recommended for people with more severe symptoms. Some antibiotics are more likely to confer resistance, so are kept as reserve antibiotics in the AWaRe book. Various diagnostic strategies have been employed to prevent the overuse of antifungal therapy in the clinic, proving a safe alternative to empirical antifungal therapy, and thus underpinning antifungal stewardship schemes.
Runs of homozygosity (ROH) are contiguous lengths of homozygous genotypes that are present in an individual due to parents transmitting identical haplotypes to their offspring. The potential of predicting or estimating individual autozygosity for a subpopulation is the proportion of the autosomal genome above a specified length, termed Froh. A research study in UK Biobank, All of Us and Million Veteran Program found that FROH declined over time in the US cohorts.
Sources: en.wikipedia.org
There is no universal storage time because stability depends on sequence, solvent, pH, concentration, and temperature. Product-specific data or stability studies provide the most reliable guidance. In the absence of such data, short-term cold storage is common.
A buffer resists pH changes when small amounts of acid or base are introduced. For peptides, pH can influence charge, solubility, and degradation rates. The appropriate buffer depends on the peptide's stability profile and intended analytical method.
Visual clarity only shows the absence of large particles or turbidity. It does not confirm identity, purity, concentration, or biological activity. Instrumental methods such as chromatography and mass spectrometry are needed for those assessments.
Short-term storage is often at refrigerated temperatures, while longer storage may use freezing. Repeated freeze-thaw cycles are generally avoided because they can promote aggregation. Container material and headspace can also affect stability.